Tags |
|
|
Links |
|
|
Advice You - How To Raise Finance For Your New Business
No matter who you are the banks, business angels or government agencies who are lending you the money all want to know that their money is safe.
Main factors
Poor management skills are the reason 80% of owner-managed firms go under. So this is the first th
Main factors
Poor management skills are the reason 80% of owner-managed firms go under. So this is the first th
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
ing that lenders will look at when considering you for a loan. Before they will lend you the money they will want to see that you have a good track record, the expertise and skills to adapt to changing financial and economic circumstances, a good product or
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
a quality service, good financial controls and ideally growth prospects. Above all they want to know that you have the ability to repay the money.
The Business Plan
All lenders will want to see a business plan. You need to make sure that this is completed
The Business Plan
All lenders will want to see a business plan. You need to make sure that this is completed
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
correctly as this will explain why you need the money, how much you want and for how long. Including cash flow projections to demonstrate how the loan will be serviced and eventually repaid. Both the business plan and the cash flow forecast also need to be
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
realistic.
Be Careful
All lenders are sceptical of over-optimistic forecasts. It is better to be cautious. If an accountant has prepared your cash flow forecast, lenders know the figures will all add up. However, they will want to know that you have a real
Be Careful
All lenders are sceptical of over-optimistic forecasts. It is better to be cautious. If an accountant has prepared your cash flow forecast, lenders know the figures will all add up. However, they will want to know that you have a real
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
understanding of the rationale behind the figures.
Projections
Projections are based on assumptions, so you must say what these are. Lenders question everything, it's their job. Many business plans fail to impress lenders because they fail to consider all
Projections
Projections are based on assumptions, so you must say what these are. Lenders question everything, it's their job. Many business plans fail to impress lenders because they fail to consider all
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
eventualities or come up with alternative strategies should problems arise. It is imperative that you look at all eventualities and have at least one back up plan.
Past Performances
Ultimately all lenders have to decide whether or not your proposal is vi
Past Performances
Ultimately all lenders have to decide whether or not your proposal is vi
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
ble, based on your past performance and their knowledge of the market. So if you are an established business, lenders will want to see your annual accounts (ideally for the last three years) to review historic trading performance and identify any trends.
Yo
Yo
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
ur Current Position
All lenders will want to know your up-to-date trading position and to see regular management accounts. They will also want to look at bank statements and VAT returns. Balance sheets represent a one-time snapshot of the business. So lende
All lenders will want to know your up-to-date trading position and to see regular management accounts. They will also want to look at bank statements and VAT returns. Balance sheets represent a one-time snapshot of the business. So lende
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
rs may dig deeper to find the real cash-producing capacity and the extent to which any liabilities might become real.
Your Accounts
The lender will also want to know the true rather than book value of all your assets, should it become necessary to consider
Your Accounts
The lender will also want to know the true rather than book value of all your assets, should it become necessary to consider
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
a forced sale. Notwithstanding your budgets and cash flow forecasts, lenders will use some basic tools to assess your plans, such as a simple break-even analysis. At the very least, you should be able to provide a rough figure for overheads and other fixed
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
costs, and an assessment of the gross margin expected on sales.
Lenders concerns
Lenders worry about over-reliance on too few suppliers and/or customers, often a major problem for small businesses. This is where a late payment of a big invoice could destro
Lenders concerns
Lenders worry about over-reliance on too few suppliers and/or customers, often a major problem for small businesses. This is where a late payment of a big invoice could destro
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
y your cash flow. And a key customer going bust is often fatal. If this is your situation, your business plan should show how you intend to rectify this weakness.
Security and Commitment
Security is an important aspect of a lending decision although it is
Security and Commitment
Security is an important aspect of a lending decision although it is
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
never the main factor. It is there to provide a guarantee of repayment should all else fail. Some lenders feel that a director's guarantee supported by personal assets is enough.
Investment and Capital
Lenders like to see owner/managers invest their own mo
Investment and Capital
Lenders like to see owner/managers invest their own mo
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
ey in their businesses. It's also a fallback against potential losses. However, while this may show commitment, it's no substitute for adequate capital resources. Insufficient capital or under-capitalisation are also major contributors to many business failu
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
res. So asking for too small a loan may be counter-productive.
Looking at Your Debt Sensibly
Many small businesses rely on an overdraft when they might be better off with something more structured, like a term loan. A lender may even suggest you do not nee
Looking at Your Debt Sensibly
Many small businesses rely on an overdraft when they might be better off with something more structured, like a term loan. A lender may even suggest you do not nee
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
d to borrow at all: factoring invoices, hire purchase or leasing may be better ways of releasing cash.
Lenders' Favourite Tipple
Every lender will look at seven key areas before lending: CAMPARI:
• Character: do you give the impression you will make your
Lenders' Favourite Tipple
Every lender will look at seven key areas before lending: CAMPARI:
• Character: do you give the impression you will make your
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
plans a reality?
• Ability: do you and your people have the right skills and experience?
• Means: what are the business's and your own personal assets?
• Purpose: what is the purpose of the loan? Is it for a sensible cash-generating plan? Few
• Ability: do you and your people have the right skills and experience?
• Means: what are the business's and your own personal assets?
• Purpose: what is the purpose of the loan? Is it for a sensible cash-generating plan? Few
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
lenders will lend money to pay debts or to give you a nice pay rise.
• Amount: ask for enough money, but not for more than you need. What funds will you put in to reduce the lender's risk?
• Repayment: prove you will be able to repay the money with
• Amount: ask for enough money, but not for more than you need. What funds will you put in to reduce the lender's risk?
• Repayment: prove you will be able to repay the money with
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
a realistic cash flow forecast.
• Insurance: lenders are wary of under-insured businesses. An uninsured loss could destroy you, after all.
If your lender does not ask for all of this information then you should look at another more professional lender
• Insurance: lenders are wary of under-insured businesses. An uninsured loss could destroy you, after all.
If your lender does not ask for all of this information then you should look at another more professional lender
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.adviceyou.org.ua/article/17839/adviceyou-How-To-Raise-Finance-For-Your-New-Business.html">How To Raise Finance For Your New Business</a>
BB link (for phorums):
[url=http://www.adviceyou.org.ua/article/17839/adviceyou-How-To-Raise-Finance-For-Your-New-Business.html]How To Raise Finance For Your New Business[/url]
Related Articles:
Quality Control Aspects Of Garment Exports
Long Forgotten? Stir Old Accounts Back to Life
Bookmark it:
|